Donald Bergstrom
2021
In 2021, Donald Bergstrom earned a total compensation of $3.5M as President, Research Development at Relay Therapeutics, a 76% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $237,500 |
|---|---|
| Option Awards | $1,618,816 |
| Salary | $475,000 |
| Stock Awards | $1,198,716 |
| Other | $9,760 |
| Total | $3,539,792 |
Bergstrom received $1.6M in option awards, accounting for 46% of the total pay in 2021.
Bergstrom also received $237.5K in non-equity incentive plan, $475K in salary, $1.2M in stock awards and $9.8K in other compensation.
Rankings
In 2021, Donald Bergstrom's compensation ranked 3,773rd out of 12,415 executives tracked by ExecPay. In other words, Bergstrom earned more than 69.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,773 out of 12,415 | 70th |
Division Manufacturing | 1,542 out of 5,508 | 72nd |
Major group Chemicals And Allied Products | 626 out of 2,378 | 74th |
Industry group Drugs | 555 out of 2,099 | 74th |
Industry Biological Products, Except Diagnostic Substances | 146 out of 449 | 68th |
Source: SEC filing on April 14, 2022.
Bergstrom's colleagues
We found four more compensation records of executives who worked with Donald Bergstrom at Relay Therapeutics in 2021.